Clinical Trial Update: The Effects of Ripasudil in Patients With FED Undergoing Femtosecond Laser Assisted Cataract Surgery [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is recruiting to evaluate Ripasudil in patients with Fuchs' Endothelial Dystrophy undergoing femtosecond laser-assisted cataract surger…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Fuchs Endothelial Dystrophy

Drugs mentioned

• Ripasudil (Ripasudil)

Snippet

Sponsor: Singapore Eye Research Institute | Conditions: Fuchs' Endothelial Dystrophy, Cataract | Phase 3 | Status: RECRUITING